Abiomed, Inc. (ABMD) Tops Q4 EPS by 7c; Revs Heavy

May 16, 2012 7:01 AM EDT
Abiomed, Inc. (NASDAQ: ABMD) reported Q4 EPS of $0.13, $0.07 better than the analyst estimate of $0.06. Revenue for the quarter came in at $37.3 million versus the consensus estimate of $34.98 million.

For earnings history and earnings-related data on Abiomed, Inc. (ABMD) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings